+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alli"

Global Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 110 Pages
  • Global
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Alli market is a segment of the anti-obesity drug industry. Alli is a weight loss aid that is available over-the-counter and is the only FDA-approved over-the-counter weight loss drug. Alli works by blocking the absorption of some of the fat from the food that is eaten. It is intended to be used in conjunction with a reduced-calorie, low-fat diet and regular exercise. Alli is marketed as a weight loss aid that can help people lose more weight than diet and exercise alone. The Alli market is highly competitive, with many companies offering similar products. Some of the major players in the Alli market include GlaxoSmithKline, Novo Nordisk, Merck, and Pfizer. Other companies in the market include Allergan, Sanofi, and Johnson & Johnson. Show Less Read more